Recombinant Human CTAG1B Protein，His

CTAG1B (Cancer/testis antigen 1B) is a gene located on chromosome X that encodes a protein primarily expressed in spermatogenic cells and various cancer tissues, making it a candidate for cancer immunotherapy. Its expression in tumors and limited presence in normal tissues highlights its potential as a biomarker for diagnosis and treatment strategies in malignancies, particularly in testicular cancer and melanoma. Research has shown that CTAG1B is involved in the regulation of immune responses, where it may elicit T-cell responses against tumors. The specificity of its expression in cancer cells provides a unique opportunity to develop targeted therapies, including vaccines and antibody-based treatments. Studies have also indicated that CTAG1B may be part of the larger category of cancer/testis antigens, which are of significant interest for their potential to differentiate between tumor and normal tissues, thus enabling a more personalized approach to cancer treatment. Investigating the recombinant form of CTAG1B can further elucidate its structure and function, paving the way for novel therapeutic interventions and enhancing the effectiveness of existing cancer vaccines. Overall, the research on CTAG1B recombinant protein represents a promising frontier in the development of immunotherapeutic strategies aimed at harnessing the immune system to combat cancer.